Key Finding
Acupuncture combined with conventional medicine significantly improved disability status and quality of life in multiple sclerosis patients compared to medicine alone, with minimal adverse effects.
Researchers reviewed 11 clinical studies involving 574 patients to examine whether acupuncture helps people with multiple sclerosis (MS), a chronic condition affecting the nervous system. Multiple sclerosis causes symptoms like fatigue, pain, mobility problems, and reduced quality of life, and current treatments don't work for everyone.
The research team searched major medical databases for randomized controlled trials comparing acupuncture treatment to standard care. They analyzed the quality of each study and combined the results to see if acupuncture made a difference.
The findings showed that when acupuncture was added to conventional medicine, patients experienced greater improvements in disability status and quality of life compared to those receiving medicine alone. The benefits appeared meaningful for daily functioning. Importantly, acupuncture-related side effects were rare and mild when they did occur, suggesting it's a relatively safe option.
However, the researchers noted some important limitations. The studies varied considerably in how they were conducted, which made it harder to draw firm conclusions. The overall quality of evidence was rated as low, meaning more rigorous research is needed to confirm these findings.
What this means for MS patients: Acupuncture may be a helpful complementary therapy alongside conventional treatment, particularly for improving function and quality of life. The safety profile appears favorable with minimal risk. However, results may vary between individuals, and acupuncture shouldn't replace proven medical treatments. If you're considering acupuncture for MS, seek a licensed acupuncturist with experience treating neurological conditions.
This systematic review and meta-analysis evaluated 11 RCTs (n=574) examining acupuncture efficacy for multiple sclerosis symptom management. Studies were sourced from major databases including PubMed, Embase, CENTRAL, and Chinese-language databases. Risk of bias was assessed using RoB 2 tools, with GRADE methodology applied for evidence certainty.
Meta-analysis demonstrated that acupuncture combined with conventional medicine produced statistically significant improvements in disability status and quality of life measures compared to medicine alone. Adverse events were infrequent and mild in severity. However, substantial heterogeneity across studies limited conclusion strength, resulting in low-grade evidence overall.
Clinical implications: Acupuncture may serve as a safe adjunctive intervention for MS patients, particularly targeting functional disability and quality of life outcomes. The favorable safety profile supports clinical consideration. However, heterogeneity in treatment protocols, outcome measures, and study design necessitates cautious interpretation. Practitioners should discuss realistic expectations with patients and emphasize acupuncture as complementary rather than primary MS therapy. Further high-quality, standardized RCTs are needed to establish definitive treatment protocols and optimal patient selection criteria.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 12-week randomized controlled trial is underway to evaluate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce body weight in patients with obesity by modulating the microbiota-gut-brain axis, assessed through fMRI, gut microbiota profiling, and serum brain-gut peptides.
📌 Acupuncture significantly reduced chronic urticaria activity scores and improved dermatology-related quality of life compared to sham acupuncture and waitlist control, performing comparably to Western medicine for symptom control.
📌 77.6% of women with moderate-to-severe menopausal symptoms experienced a clinically relevant reduction in symptoms following a standardized acupuncture protocol, with vocational education level being the most consistent predictor of treatment response.